Physician profile
Susan Mathai
NPI 1598865743
$3,395.04
in general payments reported to CMS, 2019-2025
10 companies · $93.55 in 2025
The $93.55 reported for 2025 was less than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,798 · 2020: $49.89 · 2021: $12.37 · 2023: $186 · 2024: $255 · 2025: $93.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $535.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $535.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $2,450.81 | 2019-2020 | |
| Amgen INC. | $514.36 | 2019-2025 | Krystexxa, Evenity, Prolia |
| Lilly USA, LLC | $111.54 | 2023 | Taltz |
| Genentech USA, INC. | $110.50 | 2019 | |
| Glaxosmithkline, LLC. | $104.14 | 2024 | |
| Pfizer INC. | $45.13 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $18.54 | 2019 | |
| Ucb, INC. | $14.75 | 2025 | Bimzelx |
| Merck Sharp & Dohme LLC | $12.90 | 2019 | |
| Abbvie INC. | $12.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Mathai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.